Case number 1:17-cv-01247
Sanofi et al v. Aurobindo Pharma USA, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jan 24, 2018 | 18 | Patent/Trademark Report to Commissioner (1) |
| Jan 24, 2018 | 16 | Stipulation of Dismissal (2) Docket Text: STIPULATION of Dismissal by Sanofi, Sanofi-Aventis U.S. LLC. (Fahnestock, Derek) |
| Jan 24, 2018 | 17 | Order (2) Docket Text: SO ORDERED Granting [16] Stipulation of Dismissal (***Civil Case Terminated). Signed by Judge Richard G. Andrews on 1/24/2018. (nms) |
| Jan 24, 2018 | 18 | Order (2) |
| Jan 24, 2018 | 18 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,410,167 B2; 9,107,900 B2. (Attachments: # (1) Order)(nms) |
| Jan 16, 2018 | N/A | Redaction Notice (0) Docket Text: REDACTION NOTICE: In accordance with section G of the Administrative Procedures Governing Filing and Service by Electronic Means, redacted versions of sealed documents shall be filed electronically within 7 days of the filing of the sealed document. The records of this case do not reflect the filing of a redacted version of DI #[12]. (nms) |
| Jan 16, 2018 | 15 | Redacted Document (1) Docket Text: REDACTED VERSION of [12] Letter by Sanofi, Sanofi-Aventis U.S. LLC. (Fahnestock, Derek) |
| Jan 8, 2018 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Rule 16(b) Conference set for 1/10/2018, is CONTINUED to a date to be determined. Ordered by Judge Richard G. Andrews on 1/8/2018. (nms) |
| Jan 5, 2018 | 13 | Answer to Counterclaim (10) Docket Text: ANSWER to [8] Answer to Complaint, Counterclaim by Sanofi, Sanofi-Aventis U.S. LLC.(Fahnestock, Derek) |
| Dec 28, 2017 | 11 | Order Setting Scheduling Conference (1) Docket Text: Order Setting Rule 16(b) Conference: A Scheduling Conference is set for 1/10/2018, at 3:00 PM in Chambers before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 12/28/2017. (nms) |
| Dec 19, 2017 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Steven J. Moore for Aurobindo Pharma USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg) |
| Dec 18, 2017 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [10] MOTION for Pro Hac Vice Appearance of Attorney Steven J. Moore of Withers Bergman LLP, filed by Aurobindo Pharma USA, Inc.. Signed by Judge Richard G. Andrews on 12/18/2017. (nms) |
| Dec 15, 2017 | 8 | Answer to Complaint (22) Docket Text: ANSWER to [1] Complaint, Affirmative Defenses, and COUNTERCLAIMS against Sanofi, Sanofi-Aventis U.S. LLC by Aurobindo Pharma USA, Inc..(Connolly, Arthur) Modified on 12/18/2017 (nms). |
| Dec 15, 2017 | 9 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Aurobindo Pharma USA, Inc.. (Connolly, Arthur) |
| Dec 15, 2017 | 10 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Steven J. Moore of Withers Bergman LLP - filed by Aurobindo Pharma USA, Inc.. (Connolly, Arthur) |
| Dec 13, 2017 | N/A | SO ORDERED (0) |
| Dec 12, 2017 | 7 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to Respond to the Complaint to December 15, 2017 - filed by Aurobindo Pharma USA, Inc.. (Connolly, Arthur) |
| Nov 21, 2017 | 6 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Sanofi-Aventis U.S. LLC, Sanofi. Aurobindo Pharma USA, Inc. served on 11/21/2017, answer due 12/12/2017. (Fahnestock, Derek) |
| Sep 6, 2017 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Aug 31, 2017 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Aurobindo Pharma USA, Inc. on 8/31/2017. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (nmfn) |
| Aug 31, 2017 | 1 | Complaint (11) |
| Aug 31, 2017 | 1 | Exhibits A & B (56) |
| Aug 31, 2017 | 1 | Civil Cover Sheet (1) |
| Aug 31, 2017 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmfn) |
| Aug 31, 2017 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 7/21/2017. Date of Expiration of Patent: 4/16/2029. Thirty Month Stay Deadline: 1/21/2020. (nmfn) |
| Aug 31, 2017 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,410,167 B2; 9,107,900 B2. (nmfn) |
| Aug 31, 2017 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Sanofi for Sanofi-Aventis U.S. LLC filed by Sanofi, Sanofi-Aventis U.S. LLC. (nmfn) |
| Aug 31, 2017 | 1 | Main Document (11) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against Aurobindo Pharma USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2215090.) - filed by Sanofi-Aventis U.S. LLC, Sanofi. (Attachments: # (1) Exhibits A & B, # (2) Civil Cover Sheet)(nmfn) |
| Aug 31, 2017 | 1 | Complaint* (1) |
